UnitedHealth Group CEO Stephen Hemsley, who replaced Andrew Witty, said he has the right strategy in place “for the era ahead.”

Even UnitedHealth will struggle to overcome parasitic medical costs that Warren Buffett once called a tapeworm eating away at U.S. economic competitiveness. The $300 billion healthcare conglomerate reinstalled Chairman Stephen Hemsley as CEO and yanked its financial guidance.

UnitedHealth Group shares rebounded modestly Wednesday following yesterday's crash, with analysts from UBS, Oppenheimer, and Morgan Stanley leaving their ratings unchanged after the health insurer pulled its outlook and announced its CEO had stepped down.

UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

UnitedHealth's stock has plunged nearly 40% year-to-date as the company has battled a series of crises. Can the healthcare giant turn it around? Seeking Alpha analysts weigh in.

Wall Street is wary of UnitedHealth Group's (UNH) near-term prospects after the company's sudden CEO shake-up and its pulling of 2025 financial guidance on Tuesday. Bank of America Securities, for one,

Nvidia and AMD extend gains after the chip makers sign deals with Saudi Arabia, shares of Super Micro Computer surge for a second day, and UnitedHealth claws back some losses from the previous session.